IMS Health purchased for $5.2 billion

IMS Health will be acquired by TPG Capital and the Canadian Pension Plan Investment Board, an investment management organization, for $5.2 billion.

The acquisition also covers IMS Health's outstanding debt, equaling roughly $1.3 billion as of September 30, according to third quarter reports.

A spokesperson for IMS Health said the company will continue operating under its flagship name—IMS Health. There are no immediate plans to change senior management, the spokesperson said. IMS Health “will continue our focus on expanding into new markets, further improving the quality and depth of offerings we deliver to our clients and playing a bigger role in the healthcare market,” David Carlucci, IMS chairman and CEO, said in a statement. The acquisition is expected to be completed by the end of the first quarter, 2010.

IMS Health's third quarter revenue was $540.8 million—down from $573.7 during the same period last year.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.